Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain

다국어 초록 (Multilingual Abstract)

Parkinson’s disease (PD) is a chronic and progressive movement disorder, resulting from the degeneration of the nigrostriatal dopaminergic (DA) pathway. The cause of DA neuronal loss in PD is still unclear; however, accumulating evidence suggests that treatment with certain flavonoids can induce neuroprotective properties, such as activation of mammalian target of rapamycin complex 1 (mTORC1) and anti-inflammatory activities in animal models of PD. The bioflavonoid myricitrin is well known for its anti-inflammatory and antioxidant properties. However, it is unclear whether systemic treatment with myricitrin can protect neurons against neurotoxin-induced DA degeneration in vivo via the preservation of tyrosine hydroxylase (TH) activity and the induction of mTORC1 activation. Our results found no significant neuroprotective effect of 30 mg/kg myricitrin on 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in the substantia nigra (SN) of mice. However, myricitrin treatment with 60 mg/kg protected DA neurons against 6-OHDA-induced neurotoxicity. Moreover, myricitrin treatment preserved TH enzyme activity and mTORC1 activation in nigral DA neurons in the SN of 6-OHDAtreated mice, and its treatment suppressed an increase in tumor necrosis factor-α expression in activated microglia. These results suggest that myricitrin may have neuroprotective properties linked to mTORC1 activation, preservation of TH enzyme activity, and anti-neuroinflammation for preventing DA neuronal degeneration in vivo.

참고문헌 (Reference)

1 Dunkley PR, "Tyrosine hydroxylase phosphorylation:Regulation and consequences" 91 : 1025-1043, 2004

2 Brunet A, "Transcription-dependent and -independent control of neuronal survival by the PI3KAkt signaling pathway" 11 : 297-305, 2001

3 Choi SH, "Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo" 23 : 5877-5886, 2003

4 정언주, "Silibinin Attenuates MPP1-Induced Neurotoxicity in the Substantia Nigra In Vivo" 한국식품영양과학회 17 (17): 599-605, 2014

5 Kim SR, "Prothrombin kringle-2 induces death of mesencephalic dopaminergic neurons in vivo and in vitro via microglial activation" 88 : 1537-1548, 2010

6 Fu X, "Protective role of luteolin against cognitive dysfunction induced by chronic cerebral hypoperfusion in rats" 126 : 122-130, 2014

7 Magalingam KB, "Protective mechanisms of flavonoids in Parkinson’s disease" 2015 : 314560-, 2015

8 Asano N, "Preventive effects of a flavonoid myricitrin on the formation of azoxymethane-induced premalignant lesions in colons of rats" 8 : 73-76, 2007

9 Chung YC, "Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson’s disease" 185 : 1230-1237, 2010

10 정경훈, "Nobiletin Protects Dopaminergic Neurons in the 1-Methyl-4-Phenylpyridinium-Treated Rat Model of Parkinson's Disease" 한국식품영양과학회 18 (18): 409-414, 2015

11 Park HJ, "Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action" 26 : 79-89, 2007

12 Hirsch EC, "Neuroinflammation in Parkinson’s disease:A target for neuroprotection?" 8 : 382-397, 2009

13 정운주, "Naringin: A Protector of the Nigrostriatal Dopaminergic Projection" 한국뇌신경과학회 23 (23): 124-129, 2014

14 Leem E, "Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson’s disease" 25 : 801-806, 2014

15 Chen W, "Myricitrin inhibits acrylamidemediated cytotoxicity in human Caco-2 cells by preventing oxidative stress" 2013 : 724183-, 2013

16 Domitrovic R, "Myricitrin exhibits antioxidant, antiinflammatory and antifibrotic activity in carbon tetrachlorideintoxicated mice" 230 : 21-29, 2015

17 Qin M, "Myricitrin attenuates endothelial cell apoptosis to prevent atherosclerosis: An insight into PI3K/Akt activation and STAT3 signaling pathways" 70 : 23-34, 2015

18 Wang YH, "Myricitrin alleviates methylglyoxal-induced mitochondrial dysfunction and AGEs/RAGE/NF-jB pathway activation in SH-SY5Y cells" 53 : 562-570, 2014

19 Cai Z, "Myricitrin alleviates MPP(+)-induced mitochondrial dysfunction in a DJ-1-dependent manner in SN4741 cells" 458 : 227-233, 2015

20 Zhang K, "Myricetin attenuated MPP(+)-induced cytotoxicity by anti-oxidation and inhibition of MKK4 and JNK activation in MES23.5 cells" 61 : 329-335, 2011

21 Royo M, "Mutation of regulatory serines of rat tyrosine hydroxylase to glutamate: Effects on enzyme stability and activity" 434 : 266-274, 2005

22 Qian L, "Microglial cells and Parkinson’s disease" 41 : 155-164, 2008

23 Block ML, "Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism" 76 : 77-98, 2005

24 Nam JH, "Inhibition of prothrombin kringle-2-induced inflammation by minocycline protects dopaminergic neurons in the substantia nigra in vivo" 25 : 489-495, 2014

25 Shin WH, "Induction of microglial toll-like receptor 4 by prothrombin kringle-2: A potential pathogenic mechanism in Parkinson’s disease" 5 : 14764-, 2015

26 Nam JH, "Induction of GDNF and BDNF by hRheb(S16H) transduction of SNpc neurons: Neuroprotective mechanisms of hRheb(S16H) in a model of Parkinson’s disease" 51 : 487-499, 2015

27 Manfredsson FP, "Gene therapy for neurological disorders: Challenges and future prospects for the use of growth factors for the treatment of Parkinson’s disease" 9 : 375-388, 2009

28 Cordova MM, "Further antinociceptive effects of myricitrin in chemical models of overt nociception in mice" 495 : 173-177, 2011

29 Baptista FI, "Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer’s disease" 5 : 83-92, 2014

30 최성민, "Effects of Flavonoid Compounds on β-amyloid-peptide-induced Neuronal Death in Cultured Mouse Cortical Neurons" 의과학연구소 50 (50): 45-51, 2014

31 Kim SR, "Dopaminergic pathway reconstruction by Akt/Rheb-induced axon regeneration" 70 : 110-120, 2011

32 Savitt JM, "Diagnosis and treatment of Parkinson disease: Molecules to medicine" 116 : 1744-1754, 2006

33 Cui QJ, "Continual naringin treatment benefits the recovery of traumatic brain injury in rats through reducing oxidative and inflammatory alterations" 39 : 1254-1262, 2014

34 Sato T, "Characterization of the RhebmTOR signaling pathway in mammalian cells: Constitutive active mutants of Rheb and mTOR" 438 : 307-320, 2008

35 Datta SR, "Cellular survival: A play in three Akts" 13 : 2905-2927, 1999

36 Pereira M, "Amphetamine-induced appetitive 50-kHz calls in rats: A marker of affect in mania?" 231 : 2567-2577, 2014

37 Nussbaum RL, "Alzheimer’s disease and Parkinson’s disease" 348 : 1356-1364, 2003

38 Timmons S, "Akt signal transduction dysfunction in Parkinson’s disease" 467 : 30-35, 2009

39 Kim SR, "AAV transduction of dopamine neurons with constitutively active Rheb protects from neurodegeneration and mediates axon regrowth" 20 : 275-286, 2012

40 Jang SW, "A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone" 107 : 2687-2692, 2010